Introduction
============

Adverse drug reactions are the most frequently reported causes of morbidity and mortality during hospitalizations ([@R1]), affecting up to 20% of all hospitalized patients in many countries and becoming an important challenge in today\'s modern medicine in terms of early recognition, proper management and their prevention ([@R2], [@R3], [@R4]). A meta-analysis made by Lazarou *et al.* (1998) to assess 39 American studies showed that the rate of serious and fatal ADRs were 6.7% and 0.3%, respectively ([@R1]).

The same authors reported that ADRs ranked between the fourth and sixth leading causes of death in the USA. In India, very few studies were conducted 5 to 10 years ago and looked at ADRs as the cause of hospital admissions. A study carried out in a tertiary referral center in Mumbai indicated that ADRs were responsible for 6.9% of total admissions ([@R5]). This author reported that deaths due to ADRs accounted for 0.8%. These days, ADR is a known cause of morbidity and mortality after hospitalization in different countries of the world ([@R3], [@R4], [@R6]).

Despite the relevance of this, there is no available data regarding the characteristics and the incidence of ADRs among hospitalized patients, in India. One study conducted on hospitalized patients by Jose *et al.* (2006) ([@R7]) in Karnataka showed that the overall incidence of ADR calculated from the patient population was only 0.15%. The reason for this low incidence was that information on the ADRs was collected only if physicians reported through the spontaneous reporting system. More recent data are thus needed to determine the actual incidence of ADRs after admission to hospital. Therefore, this study aimed at obtaining more recent and accurate data on the prevalence of ADRs among hospitalized patients and ascertaining their contributing factors.

Subjects and Methods
====================

This study was carried out in wards of a tertiary care hospital in northern India from August 2010--May 2011. This hospital is one of the largest private health facilities. The hospital was founded in 2001 and includes multispecialty and super specialty in heart. It has 7 operational theatres, 215 operational beds for inpatients with installed capacity for up to 300 beds. The hospital has standard multispecialty and cardiovascular wards from which the data was collected.

All patients admitted to the wards were included in the study and evaluated for ADRs. Only ADRs that occurred during hospital stay as a result of drugs initiated or continued in the wards were included while patients admitted to the hospital because of ADR were excluded. Intensive care units (ICUs) were excluded as the focus of the study was on ADRs occurring only among ward patients. Patient files without proper documentation were also excluded from the study. The follow up of the patients was done until patient discharge or transfer from wards to ICUs. All the information was collected from patients\' recorded files using a pre-tested data collection form. The definition of ADR used in this study was the one developed by the World Health Organization, i.e. "all the noxious and unintended drug responses which occur at doses normally used in man for the prophylaxis, diagnosis, or therapy of disease, or for the modification of physiological function" ([@R8]). In identification of ADRs, objective criteria that involve changes in laboratory values and vital signs which are not related to the disease pathology and subjective criteria which include increase in severity of symptoms or appearance of new symptoms were identified as an ADR from patients\' record file as well as from the physicians and nurses notes. Additionally, ADRs from patients\' charts that were identified by physicians or nurses were also included in the study. For validation, ADRs were discussed and confirmed with the clinical pharmacologist of the hospital after they were identified and assessed for causality, severity and preventability.

The assessment of causality was then performed for all the cases using the Naranjo\'s algorithm ([@R9]). The severity of ADRs was determined by using the modified Hartwig criteria ([@R10]) as described in [Table 1](#T1){ref-type="table"}, while the preventability of ADRs was assessed by using the modified Schumock and Thornton criteria ([@R11]). ADRs were also classified as either type A (dose-dependent and predictable from the known pharmacology) or type B (idiosyncratic, no clear dose response relationship, and not predictable from the known pharmacology) according to the system introduced by Rawlins and Thompson ([@R12]). Drugs were categorized according to the Anatomical Therapeutic and Chemical (ATC) classification system ([@R13]), and ADRs were coded according to the MedDRA terminology ([@R14]).

###### 

The modified Hartwig\'s severity classification

  Level   Description                                                                                                                                                                   Grade
  ------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------
  1       An ADR occurred but no change in treatment with suspected drug                                                                                                                Mild
  2       The ADR required that treatment with the suspected drug be held, discontinued, or otherwise changed. No antidote or other treatment required. No increase in length of stay   Mild
  3       The ADR required that treatment with the suspected drug be held, discontinued, or otherwise changed, and/or an antidote or other treatment. No increase in length of stay     Moderate
  4       Any Level 3 ADR which increases length of stay by at least one day or the ADR was the reason for admission                                                                    Moderate
  5       Any level 4 ADR which requires intensive medical care                                                                                                                         Severe
  6       The ADR caused permanent harm to the patient                                                                                                                                  Severe
  7a      The ADR was indirectly linked to death of patient                                                                                                                             Severe
  7b      The ADR was directly linked to death of patient                                                                                                                               Severe

**Statistical analysis:** The Kolmogorov-Smyrnov test was used to determine the distribution of variables. Approximately, normally distributed variables were summarized using mean and standard error of mean (mean ± SEM) while variables without normal distribution were summarized using the median, the lower (Q1) quartile, and upper (Q3) quartile. Chi-square test was applied for comparing categorical variables and multiple logistic regression with 95% confidence interval was calculated to observe relationships of predisposing factors for ADRs. P-value below 0.05 was considered as significant. All the analyses were performed using the statistical software sigma stat version 3.5.

This study was approved by Institutional Ethics Committee and by the Hospital. Patients\' written informed consent to participate in the study was obtained after comprehensive explanation of the purpose and procedure of the study. During the data collection, the patients at any risk of complication of adverse reactions were treated at spot after the response was taken. To ensure confidentiality, any attempt to collect information that would expose the identity of respondents was avoided.

Results
=======

The results were based on data collected from the records of 1033 patients (590 males, 443 females) taken from different inpatient wards. Of those patients used in the study, 167 (16.2%) experienced at least one ADR. Among those, 144 patients experienced only one ADR whilst 23 patients had more than one ADR: encountered simultaneously or successively, totaling up to 199 ADRs. The highest number of ADR observed in a single patient was four. About 9% of ADRs were caused by a combination of two or more drugs leading to the same ADR. No statistically significant difference was observed in the incidence of ADRs in both males and females (X^2^ = 1.38, *p* = 0.24), and the incidence of ADRs among different age groups was also not statistically significant (X^2^ = 3.18, *p* = 0.2). More patients admitted to the cardiovascular ward experienced ADRs (n = 54, 21.8%) than those who were in the multispecialty ward (n = 113, 14.4%) (X^2^ = 7.037, *p* \< 0.05). From multivariate analysis, the only significant indicators for the occurrence of ADRs observed in this study were the number of drugs \[OR: 1.1 (1.06--1.14), *p* \< 0.001\], length of hospitalization \[OR: 1.1 (1.04--1.14), *p* \< 0.001\], and number of diagnosis \[OR: 1.22 (1.06--1.4), *p* \< 0.05\]. The median length of hospitalization was 7 days (Q1--Q3 = 5--8 days, range = 2--37 days). The median age of patients was 61 years (Q1--Q3 = 49--68.3 years, range = 1--98 years). The top ten diagnoses of patients admitted included: hypertension 318 (13.6%), osteoarthritis 215 (9.2%), coronary artery disease 193 (8.2%), type-2 diabetes mellitus 177 (7.6%), hypothyroidism 56 (2.4%), cancer 48 (2%), fracture 38 (1.6%), urinary tract infection 30 (1.3%), dengue fever 27 (1.2%) and sepsis 26 (1.1%).

The nature of the ADRs and the drugs mostly involved are presented in [Table 2](#T2){ref-type="table"}. Metabolic ADRs were the most frequent, 49 (24.6%), followed by gastrointestinal ADRs, i.e. 45 (22.6%), hematological ADRs, 28 (14.1%), and cutaneous ADRs making 21 (10.6%). The most prevalent metabolic ADR was hypokalemia, 34 (69.4%), mainly due to diuretics, 25 (73.5%).

###### 

Description of systems affected, drugs involved, and ADRs of Ward patients in the Tertiary Care Hospital in the Northern India from August 2010--May 2011

  --------------------------------------------------------------------------------------------------------------------------------------------------------
  System             Drug (number)                                                ADR (number)
  ------------------ ------------------------------------------------------------ ------------------------------------------------------------------------
  Metabolic          Diuretics (30)                                               Hypokalemia (25), hyponatremia (5)

                     Systemic corticosteroids (6)                                 Hypokalemia (4), hyperglycemia (2)

                     Antidiabetes (6)                                             Hypoglycemia (5), hypokalemia

                     Salbutamol (2)/calcium gluconate/fluconazole                 hypokalemia (4)

                     ARBs (2)/ACEi                                                Hyperkalemia (3)

  Gastrointestinal   Opioids (15)                                                 Vomiting (8), nausea (5), constipation (2)

                     Antibiotics (10)/anti-parasitics (2)/ Pyrazinamide (2)       Diarrhea (4), clostridium dificile infection (4), vomiting (3),\
                                                                                  constipation, anorexia, dryness of mouth

                     Laxatives (8)                                                Diarrhea (8)

                     Aspirin (3)                                                  GI bleeding (3)

                     NSAIDs (5)                                                   Gastritis (4), epigastric pain

  Hematological      Anticoagulants (17)                                          Thrombocytopenia (14), increased INR (3)

                     Antibiotics (9)                                              Thrombocytopenia (5), pancytopenia (3), anemia

                     NSAID/anti-neoplastics                                       Leukepenia, pancytopenia

  Cutaneous          Antibiotics (14)                                             Rash (13), swelling around the eye

                     NSAID/paracetamol/ondansetron/allopurinol                    Rash (4)

                     NSAID/acenocoumarol/warfarin                                 Angioedema, facial puffiness, ecchymosis

  CNS                Anti-psychotics (6)                                          Drowsiness (4), extrapyramidal symptoms, sedation

                     Opioids (5)                                                  Restlessness (3), drowsiness, psychosis

                     Systemic corticosteroids (2)                                 Delirium (2)

                     Aspirin + enoxaparin/Salbutamol/metoclopramide               Intracranial bleeding, tremors, extrapyramidal symptoms

  Cardiovascular     B-blockers (5)                                               Hypotension (3), bradycardia (2)

                     Ca ^+2^ channel blockers + β- blockers (3)/diuretics\        Hypotension (8)
                     (2)/ACEi + diuretic/Ca^+2^ channel blocker + diuretic/ARB\   
                     + diuretic                                                   

                     Amiodarone/hyoscine/terlipressin                             Bradycardia (3)

  Renal              Anticoagulants (9)                                           Haematuria (9)

                     Antibiotics (6)                                              Increased serum creatinine (3), acute interstitial nephritis, urinary\
                                                                                  retention, worsening of renal function

  Respiratory        ACEi (2)                                                     Dry cough (2)

                     Polymyxin B/tramadol/metoprolol                              Apnea, respiratory depression, bronchospasm

  Endocrine          Amiodarone (2)                                               Hypothyroidism (2)

  Sensory            Amikacin/nitroglycerin                                       Visual impairment, tingling sense

  Hepatic            Isoniazid                                                    Increased liver enzymes

  Muscular           Prednisolone                                                 Osteoporosis
  --------------------------------------------------------------------------------------------------------------------------------------------------------

\*CNS, central nervous system; NSAIDs, non-steroidal anti-inflammatory drugs; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blockers; GI, gastrointestinal; INR, international normalized ratio; Numbers in the parenthesis indicate frequency and single frequency wasn\'t indicated\*

None of the ADRs identified were new (unlabelled). The drugs associated with the 143 (72%) identified ADRs were clustered in a few therapeutic classes. Cardiovascular agents were responsible for 53 (26.6%) of all ADRs followed by antibiotics, 40 (20.1%), anticoagulants, 30 (15.1%), and opioids, 21 (10.6%). All the other classes accounted for 30% of the ADRs. The summary of classes of drugs responsible for ADRs is presented in [Figure 1](#F1){ref-type="fig"}.
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Using the Naranjo algorithm for causality assessment, 143 (71.9%) ADRs were identified as probable, 52 (26.1%) as possible, and 4 (2%) as definite due to re-challenge or due to the fact that the patient\'s ADR history to the same drug or cross reactivity. By using the modified Schumock and Thornton\'s criteria, 14 (7%) of the reactions were classified as definitely preventable, 58 (29.2%) were probably preventable while 127 (63.8%) were recognized to be not preventable at all.

Using modified Hartwig\'s classification it was found out that out of 199 ADRs, 95 (47.7%) were identified as mild, 89 (44.7%) as moderate and 15 (7.5%) as severe. A greater proportion of ADRs, 160 (80.4%), required some intervention (ranging from stopping the causative drug to initiation of other treatments like oral vancomycin or metronidazole for the treatment of antibiotic related diarrhea) but did not increase the length of stay (i.e. level 2 and 3) ([Table 1](#T1){ref-type="table"}). However, from analysis of records, 19 (9.5%) reactions were observed to have had an impact on the length of stay and were thus classified at level 4 ([Table 1](#T1){ref-type="table"}).

None of the ADRs resulted in death or permanent damage. However, 15 ADRs, for example acute delirium due to methyl prednisolone, acute interstitial nephritis due to amoxicillin, severe hypotension due to antihypertensive drugs, and respiratory depression due to tramadol were considered as severe that led to admission to intensive care units. Type A reactions accounted for 165 (82.9%) of the ADRs while 34 (17.1%) were type B reactions.

Discussion
==========

The overall prevalence of ADRs in this study was found to be 16.2%, which is consistent with the range of results from recent prospective studies in hospitalized patients which used a similar methodology as the present study ([@R1], [@R4], [@R6]). However, the figure in this study is higher than 3.7% and 6.9% incidences which were observed in a prospective study by Ramesh *et al.* (2003) ([@R15]) and Patel *et al.* (2007) ([@R5]), carried out in a tertiary referral center in South India and Mumbai, respectively. The findings of the study conducted by Jose *et al.* (2006) ([@R7]) in Karnataka, India showed a prevalence of 0.15% only. This is because this study used spontaneous reporting system as the only method for detecting ADRs. In the present study, ADRs were identified by prospective manner using patient chart as source of information (medical and nursing notes, laboratory diagnosis data) combined with spontaneous reporting. The most frequently encountered ADRs in this study were found to be metabolic ADRs ([Table 2](#T2){ref-type="table"}). Diuretics were the most prevalent drugs responsible for metabolic ADRs during hospitalization affecting, especially the elderly patients with a high degree of utilization of these drugs. This finding is consistent with the results of another study which included a population of elderly people ([@R2], [@R16]).

In contrast with the results of other studies which detected gastrointestinal ADRs up to a proportion of 31.3% ([@R17]) and 17.9% ([@R2]), in the present study gastrointestinal ADRs were the second most frequently manifested cases accounting for 22.6% of all ADRs. The majority of these ADRs were moderate symptoms like diarrhea and vomiting. There were only three cases of GI bleeding induced by aspirin. NSAIDs were responsible for ADRs like gastritis and epigastric pain.

In our present study, hematological and cutaneous reactions were the third and fourth most frequently manifested ADRs accounting for 14.1% and 10.6% of all ADRs, respectively. This observation is consistent with the study conducted in India by Jose *et al.* (2006) ([@R7]) who reported cutaneous reactions as the most frequent ones. A study conducted in a teaching hospital in Taiwan also reported cutaneous and hematological reactions as the most frequently manifested ADRs ([@R18]).

Recent studies conducted on hospitalized patients reported antibiotics, diuretics, and anti-diabetics as drugs most frequently linked to ADRs. NSAIDs and opioids have been implicated, particularly in studies involving surgical patients with diuretics being prevalent as causative factors in elderly patients ([@R19]). Studies that were conducted in India showed anti-neoplastics 89 (21.8%) ([@R7]) and antibiotics 55 (33.5%) ([@R20]); as the drug classes to cause most of the ADRs. Similar to results obtained by other investigators, the result of our study showed a high percentage of ADRs in patients taking antibiotics, accounted for 20.1% of all ADRs. Similarly, a research carried out in Spain by Carrasco-Garrido *et al.* (2010) ([@R21]) revealed that 22.1% of ADRs were associated with antibiotics. In Italy, Trifiro *et al.* (2005) ([@R22]) studied the incidences of ADRs and ADR related hospital admissions from emergency visits and found that antibiotics were associated with 12.9% of ADRs. Diuretics and anticoagulant drugs were the next most common drugs responsible for ADRs, accounting for 16.1% and 15.1%, respectively.

The findings of this study were in accordance with recent studies in which there was a high prevalence of older patients with cardiovascular disease ([@R23], [@R24]). Furosemide 23 (11.6%) and tramadol 21 (10.6%) were the individual drugs to cause the majority of the ADRs. A previous unpublished thesis study conducted in 2010 by Immaculich Rani in the same setting indicated that cardiovascular agents, 89 (24.7%), followed by antibiotics, 66 (18.3%), and anti-coagulants, 51 (14.2%), were the chief groups of drugs in causing ADRs while furosemide and tramadol as the individual drugs to cause most of the ADRs. Common use of these two drugs in the study hospital could be a good reason for these observed ADRs. Antibiotics were also among the most frequently prescribed drug classes in the hospital. Therefore, this excessive use of antibiotics was also responsible for an increased risk of ADRs.

According to the result of our study, type A reactions accounted for 82.9% of the ADRs while 17.1% ADRs were of type B. This was in agreement with the definition of type A reactions that are more common and predictable and type B reactions that are rare and uncommon. Moreover, our results were consistent with the reports of studies carried out in Karnataka, India and Liverpool, UK. In those reports, type A ADRs were found to be 72.5% ([@R7]) and 94.1% ([@R6]), respectively. The largest frequency of ADRs was very common in the females and has been described in various reports ([@R19], [@R25]). Wiffen *et al.* (2002) in their review identified gender to be a risk factor for development of ADR ([@R26]). Edwards *et al.* (2000) also reported that women were more susceptible to ADRs than men possibly by an association of factors such as greater concentration of adipose tissue and hormonal determinants that can affect metabolism, leading to the development of ADR ([@R27]).

In contrast, no significant difference was seen in the incidence of ADRs observed in male and female in the present study. Though the difference was not statistically significant in pediatric and adult population, relatively the highest percentage of ADRs was observed in elderly patients. Those groups of population also took more medications as compared to others to manage a number of co-morbidities associated with increase in age ([@R28]). Our findings were also in agreement with several studies. For instance, in a study conducted in Karnataka, India ([@R7]), the incidence of ADRs among elderly patients was significantly higher than among patients of other age groups. Similarly, a prospective study carried out in Punjab also showed that elderly patients had a higher incidence of ADRs ([@R29]). Studies conducted in England ([@R30]) also supported our observations. A retrospective study conducted in Australia also showed that elderly patients had a significantly higher incidence of ADR as compared to other age groups ([@R31]).

A significant association was observed between the length of hospitalization of a patient and the prevalence of ADRs in the present study (*p* \< 0.001). Patients with longer stay in the hospital had more severe conditions, many co-morbid conditions and used a higher dose of different drugs. Therefore, patients with longer hospital stay were more prone to develop ADRs. There was also a definite association between ADRs and increased length of stay found out by several studies. A study conducted by Davies *et al.*(2006) in Royals Liverpool Hospital also indicated an increase in the incidence of ADRs with increased length of hospital stay ([@R6]). Similar study conducted in south India also reported that an increase in the incidence of ADRs as the length of stay of the patient increased ([@R7]). The number of diagnosis was found to be a significant predisposing factor for ADRs in the present study multiplying the risk by 1.2 with each additional diagnosis. Patients with more co-morbid conditions are always at a higher risk of developing ADRs. As found out in the present study, the majority of the patients admitted to the target hospital had hypertension and diabetes mellitus as co-morbidities. Those diseases could be attributed to impairment of renal function which was an important factor for increasing risk of ADRs, and also using a higher number of drugs to treat the multiple diseases could result in ADRs. The result of our study was also in a complete agreement with two studies conducted by Jose *et al.* (2006) ([@R7]) and Hardmeier *et al.* (2004) ([@R32]), which identified number of diagnosis as one of the most predisposing risk factors for having ADRs.

Many studies have shown that patients taking more medications suffer from ADRs ([@R17], [@R24]). Likewise, the present study also revealed number of drugs as a significant risk factor for ADRs with each additional medication multiplying the risk of an ADR episode by 1.1 (95% CI 1.06, 1.14). The possible reasons for this fact could be the prescription of multiple drugs which increase the risk of drug-drug interactions and additive or overlapping effects of multiple medications. Since the hospital selected for this study was a cardiac with multi-specialties, the majority of the patients admitted were with a number of co-morbidities which could result in polypharmacy that lead to the occurrence of ADRs. A study conducted by Davies *et al.* (2006) in Royal Liverpool University Hospital also reported a similar finding to this study with a hazard ratio of 1.14 (95% CI 1.09, 1.20) ([@R6]).

In this study, cardiovascular ward had a higher incidence of ADRs than multispecialty ward (*p* \< 0.05), which was similar to the previous unpublished thesis study conducted by Immaculich Rani in the same setting in 2010. This was because the majority of patients admitted to this ward were hypertensive and cardiac patients with other concomitant morbidities such as diabetes, anemia, dyslipidemia and so forth which could lead to polypharmacy and multiple organ failure, increasing the chance of the occurrence of ADRs. Moreover, patients who were admitted to the cardiovascular ward were older than those who were in multispecialty ward.

As described in previous sections, ADRs can be classified into definitely preventable, probably preventable and non-preventable. A review by Kanjanarat *et al.* (2003) ([@R33]) on preventable ADRs in hospitals revealed a preventability rate of 35.2%, while the present study indicated a preventability rate of 36.2% that was almost comparable with the former.

In conclusion, the present study showed that ADRs represented a significant part of overall medical events. In this study, antibiotics, diuretics, and anticoagulant agents accounted for more than 50% ADRs. That was a signal for a need for intervention and increased prevention level in ADR related health problems. It is important to note that better knowledge of preventable ADRs could help to design preventive strategies to protect patients from being affected by these reactions unnecessarily. Preventing the preventable ADRs (36.2% of the reactions) can result in a considerable health resource savings and at the same time can help improve the quality of health care provision. Therefore, we recommend further studies by health care professionals to accurately quantify the burden and to identify the risk factors of ADRs in hospitalized patients and to plan focused preventive strategies to minimize these drug-induced harms and improve the quality of patient care.
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